Compounding pharmacy sues Eli Lilly, Novo Nordisk over GLP-1 access

Ella Jeffries / beckershospitalreview - Strive Compounding Pharmacy filed a federal antitrust lawsuit Jan. 14 against Eli Lilly and Novo Nordisk, alleging the two drugmakers used their market power to restrict access to compounded GLP-1 medications and suppress competition. The lawsuit, filed i…

AI Summary: A compounding pharmacy has taken legal aim at industry giants Eli Lilly and Novo Nordisk, alleging an anti‑competitive scheme designed to restrict access to their blockbuster GLP‑1 therapies. The lawsuit puts the pharmaceutical titans on the defensive as antitrust concerns mix with therapeutic access debates.

NVIDIA and Eli Lilly Launch $1B AI Co-Innovation Lab to Reinvent Drug Discovery

oncodaily - Dave Ricks, Chair, CEO at Eli Lilly and Company, shared Eli Lilly and Company‘s post on LinkedIn, adding: “Exciting news from the JPMorgan Healthcare Conference: Lilly and NVIDIA are joining […]

AI Summary: Eli Lilly and Nvidia have teamed up to invest up to $1 billion in a brand‑new AI lab aimed at reinventing drug discovery. This collaborative venture promises to streamline R&D with cutting‑edge artificial intelligence while hinting that pharma’s reliance on tech is evolving – and it’s not all sci‑fi smoke and mirrors.

FDA moves to remove suicide warnings from GLP-1 weight loss drugs

medicalxpress - Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not increase the risk of suicidal thoughts, and they have asked drugmakers to remove those warnings from medication labels.

AI Summary: In a surprising twist, the FDA has decided that the long‐rumored risk of suicidal ideation on popular GLP‑1 weight‐loss drugs may have been overblown. Regulators have now asked drugmakers – including Lilly and Novo Nordisk – to scrub these warnings from product labels, a move that is sure to spark both relief and raised eyebrows among critics.

H.H.S. Reverses Decision to Cut $2 Billion for Mental Health and Addiction Services

Jan Hoffman / nytimes - A day after funding termination notices went out to more than 2,000 programs nationwide, the administration reversed itself and reinstated the money.

AI Summary: After sending termination notices that slashed billions in funding for thousands of substance abuse and mental health programs, the Trump administration abruptly backtracked. Critics blasted the move as a chaotic flip-flop that left vital services in limbo and fueled political outrage.

US healthcare spending climbed 7.2% in 2024: 8 things to know

Kelly Gooch / beckershospitalreview - U.S. healthcare spending reached $5.3 trillion in 2024, a 7.2% increase from $4.9 trillion the previous year, and similar to 7.4% growth in 2023, according to a CMS analysis published Jan. 14 by Health Affairs. Eight things to know, per the analysis: 1. H…

AI Summary: New data released by CMS reveals that US healthcare spending reached an all‐time high of $5.3 trillion in 2024, with a 7.2% increase driven largely by enhanced utilization and heavier use of medical services. The report underscores persistent growth trends in spending despite ongoing cost‐containment efforts.

Senate finds UnitedHealth used ‘aggressive strategies’ in Medicare Advantage

Elizabeth Casolo / beckershospitalreview - UnitedHealth Group leveraged “aggressive strategies” to get higher-paying Medicare Advantage diagnoses, according to a Jan. 12 Senate report that Becker’s viewed. The Wall Street Journal initially covered the news. Senate Judiciary Chair Chuck Grassley, R…

AI Summary: A Senate investigation has alleged that UnitedHealth Group employed aggressive strategies to trigger more diagnoses, thereby boosting its reimbursements under Medicare Advantage. The revelations—based on thousands of pages of documentation—raise serious concerns about insurer practices and regulatory scrutiny in the Medicare market.

Merck Could Strike 30 Billion Deal for Revolution Medicines

oncodaily - According to the Financial Times, Merck is in talks to acquire Revolution Medicines, a Redwood City, California-based cancer drug developer, in a deal that could value the company at roughly […]

AI Summary: Merck is reportedly in advanced talks to acquire Revolution Medicines—a Redwood City–based cancer drug developer—in a deal that could be worth around $30 billion. A separate report adds speculative color, reinforcing market buzz about this strategic move in oncology.

Pomelo Care banks $92M to expand virtual women's health, pediatric care services

fiercehealthcare - Pomelo Care banked $92 million in series C funding as it expands beyond maternity care to to more broadly serve women's and children's health needs.

AI Summary: In a bold move that underscores investor confidence, Pomelo Care has raised $92 million in a Series C round. The funding is set to power an expansion beyond maternity care into comprehensive virtual women’s and pediatric health services—proving that when it comes to disruptive healthcare innovation, sometimes the numbers do all the talking.

New US diet guidelines push whole foods, meat and dairy

medicalxpress - The federal government has released new dietary guidelines that shift how Americans are urged to eat.

AI Summary: The federal government has unveiled a major revision in its dietary guidelines—urging Americans to favor whole foods such as lean meats, dairy and protein sources while cutting ultraprocessed items. This unexpected pivot in nutritional policy is sparking conversations about what “healthy eating” will really mean moving forward.

New Jersey system to join RWJBarnabas

Kristin Kuchno / beckershospitalreview - West Orange, N.J.-based RWJBarnabas Health and Englewood (N.J.) Health have signed a definitive agreement under which Englewood would become part of RWJBarnabas Health. The transaction is subject to state and federal regulatory approvals, according to a J…

AI Summary: A definitive agreement has been reached for Englewood Health to become part of West Orange–based RWJBarnabas Health, signaling a major consolidation in the New Jersey market. The merger is expected to drive significant investment in regional hospital networks and overcome previous regulatory hurdles, marking a new phase in local healthcare integration.

21,000 New York nurses to launch strike Jan. 12

fiercehealthcare - Twelve private sector hospitals in New York City and three in Long Island could see nurses walk off the job if no new contract deal is reached. It would be the largest nurse strike in New York City's history.

AI Summary: Reports indicate that while a large contingent of New York nurses – reportedly 21,000 – was poised to strike on January 12, negotiations at seven hospitals have led to tentative agreements that cancelled the planned walkout. Conflicting reports highlight the volatile nature of labor actions in the region.

Aktis Has First Biotech IPO of 2026, Raising $318M to Expand the Reach of Radiopharmaceuticals

Frank Vinluan / medcitynews - Aktis Oncology’s IPO will support a pipeline of “miniprotein” radioconjugates that could offer advantages over other targeted radiation cancer treatments. In addition to its internal pipeline, Aktis has a discovery partnership with Eli Lilly. The post Akt…

AI Summary: Aktis Oncology’s debut on the public market raised $318M, buoyed by a 25% first‐day bounce. The IPO not only generated strong investor enthusiasm for biotech in 2026 but also signals the company’s ambitious plans to extend its portfolio of innovative miniprotein radioconjugates for targeted cancer therapy.

Nestlé recalls baby formula over toxin risk

medicalxpress - Nestlé has announced a global recall of some baby formula products, saying they may contain a toxin that can cause food poisoning in infants.

AI Summary: Nestlé has initiated a global recall of certain baby formula products after detecting potential toxin contamination that may cause food poisoning in infants. Affected lots are being removed from retail shelves while regulators and the company work to confirm the contamination’s extent and ensure consumer safety.

A Medical Emergency 250 Miles Above Earth Forces NASA to Make a Rare Decision

discovermagazine - Learn why for only the first time in 25 years, NASA has decided to end an International Space Station mission early for medical evacuation.

AI Summary: For the first time in 25 years, NASA has abruptly decided to curtail an ISS mission due to an in‐orbit medical emergency affecting one of its astronauts. The situation forced cancellation of scheduled spacewalks and spurred urgent preparations for an early crew return to Earth.

House approves 3-year ACA subsidy extension

Andrew Cass / beckershospitalreview - The House of Representatives voted to extend the ACA enhanced tax credits that expired at the end of 2025 for three years, which now heads to the Senate. The 230-196 vote followed a Democrat-led discharge petition that reached the required 218 representat…

AI Summary: Multiple reports reveal that lawmakers are urgently working to extend enhanced ACA tax credits beyond 2025. The House has approved a three‐year extension to guarantee affordable coverage, as Congress debates renewing these critical subsidies for millions of Americans.

OpenAI Launches ChatGPT Health: 5 Things to Know

Katie Adams / medcitynews - OpenAI announced a new dedicated platform for health conversations. The company said the new offering is not intended for medical diagnosis or treatment — but rather to provide support for personal health navigation.The post OpenAI Launches ChatGPT Health…

AI Summary: OpenAI has rolled out ChatGPT Health, a dedicated platform enabling health‐focused conversations by integrating data from health apps and medical records. Although not intended for diagnosis, the move sparks wry remarks as the tech giant ventures boldly into sensitive, regulated health terrain.

RFK Jr.'s CDC whacks 6 vaccines from childhood recommendation list after opaque monthlong review

fiercehealthcare - The Centers for Disease Control and Prevention (CDC) has upended the immunization schedule for children in the United States, eliminating six of the 17 vaccines that were previously recommended to protect them from disease.

AI Summary: In an unexpected twist to the longstanding immunization program, the CDC has eliminated six previously universal childhood vaccines following a monthlong review—sparking debates and eyebrow raises among healthcare officials. The policy change now tailors recommendations to higher-risk groups while shifting away from a one‐size‐fits‐all approach.

UK starts ban on junk food ads on daytime TV and online

medicalxpress - New regulations come into force Monday in Britain banning daytime TV and online adverts for so-called junk foods, in what the government calls a "world-leading action" to tackle childhood obesity.

AI Summary: British regulators have implemented new rules banning junk food advertisements on daytime TV and online platforms. The measures—targeting products like soft drinks, chocolate, pizza, and ice cream—are part of a government drive to curb unhealthy food marketing and protect public health, especially among younger audiences.

FDA rejects Corcept’s cortisol-targeting drug for Cushing’s syndrome

Ayisha Sharma / endpoints - Corcept Therapeutics failed to secure US approval for its drug candidate as a hormonal disorder treatment. The FDA rejected Corcept’s selective cortisol modulator relacorilant for Cushing’s syndrome, according to a company

AI Summary: Corcept Therapeutics has hit a regulatory roadblock as the FDA rejected its cortisol‐targeting relacorilant, intended for hormonal disorders. The decision forces the company to reassess its strategy, highlighting the challenges inherent in advancing novel hormonal therapies amid strict regulatory scrutiny.